Tuesday, November 30 - Welcome & Opening
09:00 - 14:00	Exhibition set-up
15:00 - 17:00	Opening of the registration desk
16:00 - 17:00	WELCOME RECEPTION

SESSION I - Overview - Natural Peptides To Drugs
17:00 - 17:15	Opening ceremony & Welcome notes
17:15 - 18:00	Opening Lecture:  Prof. Robin OFFORD Geneva University Medical School, Switzerland Improving on nature: therapeutic enhancement of polypeptides
18:00 - 19:30	Prof. Hans Vogel University of Calgary, Alberta, Canada Potential use of antimicrobial peptides as future antibiotics
	Dr Adriano Pimenta Federal University of Minas Gerais, Belo Horizonte, Brazil Small peptides, big world: prospecting, characterizing and optimizing structures of some neglected bioactive peptides from arthropod venoms
	Dr Corina Borghouts-Heinz Georg Speyer Haus, Institute for Biomedical Research, Frankfurt am Main, Germany Interference with crucial signaling events in cancer cells by peptide aptamers and targeted protein degradation vehicles (TPDV)
	Prof. Michael J. Tyler Department of Environmental Biology, University of Adelaide, South Australia Frog peptides in modern and historical use
	Dr Marina Rautenbach Department of Biochemistry, University of Stellenbosch, Matieland, South Africa Antifungal peptides with haemolytic activity directed against Plasmodium falciparum
	Dr Sophie Michalet Atheris Laboratories, Geneva, Switzerland In vivo pharmacokinetic and pharmacodynamic studies of peptide drugs by mass spectrometry
	Dr Charlotte Hummer Vad Novozymes A/S, Bagsvćrd, Denmark Unlocking the magic of nature - Development and discovery of a new class of antimicrobial compounds
20:00 -	SWISS-EVENT DINNER

Wednesday, December 1 - From Natural Peptides
SESSION II - Toxins, Antimicrobial Peptides & Hormones
8:30 - 9:15	Invited Lecture: Prof. Paul ALEWOOD University of Queensland, Australia Drugs from venoms
9:15 - 10:00	Invited Lecture: Prof. Bob HANCOCK University of British Columbia, Vancouver, Canada Cationic host defence peptides as antibiotics and modulators of innate immunity
10:00- 10:30	COFFEE BREAK & POSTERS
10:30 - 11:15	Invited Lecture: Prof. Tomas GANZ David Geffen School of Medicine at UCLA, USA Hepcidin, a new iron-regulatory and host-defense hormone
11:15 - 11:50	Prof. Shigesada Higuchi Showa University School of Pharmaceutical Sciences, Tokyo, Japan Novel peptides from the ACEI/BPP-CNP precursor in crotaline snakes
	Dr Per Holse Mygind Novozymes A/S, Bagsvćrd, Denmark Characterization of plectasin - A novel antimicrobial defensin
12:30 - 16:30	JOURNEY BY TRAIN TO GORNERGRAT MOUNTAIN (3'135 m) LUNCH BREAK OPEN AIR ACTIVITIES
SESSION III - Therapeutic Targets & Mode of Action
17:30 - 18:15	Invited Lecture: Prof. George CHANDY University of  California Irvine, USA Ion Channels in lymphocytes : therapeutic targets for autoimmune diseases
18:15 - 18:50	Dr Ron Hogg University of Geneva, Switzerland Importance of natural peptides in the design of drugs targeted to ligand-gated ion channels
	Prof. Eefjan Breukink Dept. Biochemistry of Membranes, Utrecht University, The Netherlands The magic bullet nisin: structural insights and an additional mechanism of action?
18:50 - 19:05	COFFEE BREAK
19:05 - 20:30	Dr Vincent Dive CEA, Centre d'Etude Nucleaires de Saclay, Gif/Yvette, France ACE: Structure and Function - Insights from selective inhibitors
	Dr Arya Biragyn GRC, National Institute on Aging, National Institutes of Health, Baltimore, USA Beta-defensins as immunomodulator and vaccine carrier: Self-tumor antigens are cross-presented and rendered immunogenic through CCR6 when targeted to APCs as β-defensin fusions
	Prof. John Marchalonis University of Arizona/ College of Medicine, Tucson, AZ, USA Control of helper T cell polarization by T cell receptor derived peptides
	Prof.  Marguerite Kay Institute for Biomedical Sciences and Technology, Temple, TX, USA Physiologic autoantibodies and their neoantigens as therapeutic modalities
	Dr Shubh Sharma Palatin Technologies, Cranbury, NJ, USA Metal-ion Induced Distinctive Array of Structures: A Novel Approach for Rational Design of Peptide Based Drugs
	Dr Philippe Favreau Atheris Laboratories, Geneva, Switzerland Venom proteomics and drug discovery: direct de novo sequencing of bioactive peptides from complex mixtures
20:30 -	FREE EVENING

Thursday, December 2 - Through Development
SESSION IV - Structure-Function Studies & Modelling
8:30 - 9:15	Invited Lecture: Prof. André MÉNEZ CEA-Saclay, France From Toxins to Drugs
9:15 - 10:30	Dr Laszlo Otvos OLPE, LLC, Audubon, PA, USA Multifunctional antibacterial peptides
	Prof. Jon Nissen-Meyer Department of Molecular Biosciences, University of Oslo, Norway Structure-function analysis of the pediocin-like antimicrobial peptides: their three-dimensional structure, orientation in membranes, and domain functions
	Prof. Gopalakrishnakone Ponnampalam National University of Singapore, Faculty of Medicine, Singapore Anti-inflammatory peptides designed from phospholipase A2 inhibitory protein from the serum of python reticulates
	Dr Wim Jan Vrijbloed Polyphor Ltd, Allschwil, Switzerland Protein epitope mimetics (PEM) selectively targeting HIV-1 fusion events via the cellular coreceptor CXCR4
10:30 - 11:00	COFFEE BREAK & POSTERS
SESSION V - Drug Design & Delivery
11:00 - 11:45	Invited Lecture: Prof. Richard DIMARCHI Indiana University, USA The Emergence of Chemical Biotechnology as a Means to Optimal Protein-Based Medicines
11:45 - 12:40	Prof. David J. Craik Institute for Molecular Bioscience, University of Queensland, Brisbane, Australia The cyclic cystine knot as a scaffold for peptide drug delivery
	Prof. Paul Robert Hansen Department of Natural Sciences, RVAU, Copenhagen, Denmark Design, synthesis and characterization of novel antibacterial lysine-peptoid hybrids
	Dr Rinaldo Zurbriggen Pevion Biotech, Berne, Switzerland Peptides and peptidomimetics delivered by immunostimulating reconstituted influenza virosomes
12:40 - 14:00	LUNCH BREAK
14:00 - 17:00	OPTIONAL ACTIVITIES & NETWORKING SESSIONS
SESSION VI - Production, Formulation & Manufacturing
17:00 - 17:45	Invited Lecture: Dr Peter HOFFMANN Genzyme Pharmaceuticals, USA As Hannibal Delivered Elephants Across the Alps : Genzyme Delivers Peptides and Proteins Across the Blood Brain Barrier
17:45 - 19:30	Dr Andy Strong Dictagene, Lausanne, Switzerland Fmoc synthesis of Interferon-alpha using long peptide thioesters prepared on a safety-catch resin
	Prof. Jin-Xing Wang School of Life Sciences, Shandong University, Jinan, China Molecular cloning, characterization and high level expression of shrimp antimicrobial peptides, Ch-penaeidins, in E. coli and Pichia pastoris
	Dr Michael Kleine Planton GmbH, Kiel, Germany Plant made pharmaceuticals (PMP)  –  A production system for anti-microbial peptides
	Prof. Keith Rose Department of Structural Biology and Bioinformatics, University Medical Center, Geneva, Switzerland Covalent capture – a useful purification process for synthetic and recombinant polypeptides
	Dr Reto Stöcklin Atheris Laboratories, Geneva, Switzerland A new affinity tag removal system in peptide synthesis and protein expression
	Dr Vincent Bille UCB-Bioproducts, Belgium Drug substance (API) and drug product manufacturing process development stages through late pre-clinical and clinical studies
20:00 -	GALA DINNER

Friday, December 3 - To Clinics
SESSION VII - Development & Clinical Trials
8:30 - 9:15	Invited Lecture: Dr Stephen SCHNEIDER Trimeris, USA Development of the HIV Fusion Inhibitors Fuzeon and T-1249
9:15 - 10:30	Dr José de Chastonay Bachem Americas, King of Prussia, PA, USA The outlook for peptide drugs and the intricate relationship between the API manufacturer and their sponsor
	Dr Chandra Panchal Procyon Biopharma Inc., Montreal, Canada Development of a novel peptide drug PCK3145 derived from the naturally occurring prostate secretory protein PSP94
	Dr Thierry Abribat Theratechnologies, Montreal, Quebec, Canada Physiological peptides as drugs : the example of GHRH analogues
	Dr Shubh Sharma Palatin Technologies, Cranbury, NJ, USA PT-141: a melanotropin hormone analog for the treatment of sexual dysfunction
10:30 - 11:00	COFFEE BREAK & POSTERS
SESSION VIII - Route to Clinic
11:00 - 11:45	Closing Lecture: Dr Timothy WELLS Serono International, Switzerland Biologics – the fast route to the clinic
11:45 - 13:00	Roundtable: Peptides as Drugs: What for the Future ?
13:00 - 13:10	Closing Notes
13:10 -	FAREWELL COCKTAIL / LUNCHEON